Medicus Pharma Ltd MDCX

$3.58 -1.03 (-22.26%)

Valuation

Market cap
5,819,000
Revenue TTM
$0
Net income TTM
$-35,460,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
-10.45

Trading

Volume
123,182
Avg volume
5,869,468
Day's range
$3.58 – $4.69
Shares out
63,181,000
Stochastic %K
9%
Beta
0.30
Analysts
Strong Sell
Price target
$4.50

Price

Company profile

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly kno...

Show more

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
610 636 0184
Website
https://medicuspharma.com
Address
300 Conshohocken State Road, Suite 200, West Conshohocken, United States

Latest news

Stocktwits

TwongStocks Oct 12, 8:12 PM
Today's reverse split results. $DFLI 1 for 8 Previous close $0.4719, $3.7752 split-adjusted Today's high $3.95 Today's close $3.54 🔴Down 6.23% $MDCX 1 for 50 Previous close $0.0921, $4.605 split-adjusted Today's high $4.69 Today's close $3.58 🔴Down 22.26% $NIVF 1 for 4 Previous close $0.0721, $0.2884 split-adjusted Today's high $0.31 (premarket) Today's close $0.2361 🔴Down 18.13% $NXGL 1 for 20 Previous close $0.2003, $4.006 split-adjusted Today's high $7.93 (premarket) Today's close $3.81 🔴Down 4.89% $ZBAO 1 for 50 Previous close $0.0574, $2.87 split-adjusted Today's high $3.05 Today's close $2.40 🔴Down 16.38%
0 replies
Cullousus Oct 12, 7:34 PM
$MDCX gonna suck retail dry here
0 replies
Zackpedia Oct 12, 4:42 PM
$MDCX Back to 3.66 post RS or 7 cents, you could’ve…
0 replies
flowerchefstocks Oct 12, 2:47 PM
$MDCX The reverse stock split was a NASDAQ compliance move. The reason investors fear reverse stock splits is because of the dilution that follows. Getting rid of yorkville seems like that was a serious move to tell the market hes not diluting down here. The next step is a licensing deal for skinject and its definately going to fill the company coffers. That is what I think everybody is missing and will propel this higher. they have been negotiating with partners for a year. They are going to sell it an get what they can for it because that is their business model and they upgrade to Pfizer ADC tech.
1 replies
ka1954 Oct 12, 2:36 PM
$MDCX fucking turd
0 replies
cheapostock Oct 12, 1:46 PM
$MDCX any news with rs halt? Why it gapped up?
1 replies
TwongStocks Oct 12, 11:02 AM
$DFLI $MDCX $NIVF $NXGL $ZBAO All five have reverse splits today, full details in the quoted post. Currently halted due to the RS, trading resumes at 9:00am ET.
0 replies
ellistattersall Oct 12, 9:25 AM
$MDCX Nothing has changed with the company
1 replies